Sakamoto Takatoshi, Kachi Shigeto, Nakamura Shohei, Yuasa Hiroshi
Department of Pharmaceutical Technology, School of Clinical Pharmacy, College of Pharmaceutical Sciences, Matsuyama University.
Pharmaceuticals Division, Kyowa Chemical Industry Co., Ltd.
Chem Pharm Bull (Tokyo). 2019;67(3):284-288. doi: 10.1248/cpb.c18-00588.
This study aimed to clarify the effects of magnesium oxide (MgO) on the hardness of orally disintegrating tablets (ODTs) during storage. ODTs containing a range of MgO concentrations were prepared by direct powder compression and stored for up to 4 weeks in an unpackaged condition at 40°C, with 75% relative humidity. Tablets that did not contain MgO showed a significant decrease in hardness after one week in storage, while those containing MgO at a mass fraction of ≥4% maintained their hardness for up to 4 weeks. The tablet disintegration times after storage were equivalent to those observed before storage (approximately 30 s), regardless of the MgO level. Furthermore, the dissolution behavior of a model drug (acetaminophen) from the ODTs was not affected by the level of MgO. These findings revealed that the addition of MgO suppressed the reduction in ODT hardness during storage in the unpackaged state, without delaying tablet disintegration or inhibiting drug release.
本研究旨在阐明氧化镁(MgO)对口腔崩解片(ODT)在储存期间硬度的影响。通过直接粉末压片法制备了含有一系列MgO浓度的ODT,并在40°C、相对湿度75%的无包装条件下储存长达4周。不含MgO的片剂在储存1周后硬度显著下降,而MgO质量分数≥4%的片剂在长达4周的时间内保持其硬度。储存后的片剂崩解时间与储存前观察到的时间相当(约30秒),与MgO水平无关。此外,模型药物(对乙酰氨基酚)从ODT中的溶出行为不受MgO水平的影响。这些发现表明,添加MgO可抑制无包装状态下储存期间ODT硬度的降低,而不会延迟片剂崩解或抑制药物释放。